Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc NUMIF


Primary Symbol: T.NUMI

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoactive Fungi Species

PR Newswire June 24, 2021

Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange

PR Newswire June 18, 2021

Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial

GlobeNewswire June 17, 2021

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation

Canada NewsWire May 13, 2021

Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

GlobeNewswire May 11, 2021

Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application

Canada NewsWire May 11, 2021

Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD

Canada NewsWire May 10, 2021

Top Mushroom Stocks Sprouting on the Health and Witness Trend

Press Releases May 4, 2021

Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol

GlobeNewswire May 4, 2021

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial Collaboration with MAPS PBC

Canada NewsWire April 29, 2021

Psilocybin May Be Helpful for Those with Traumatic Brain Injury

Press Releases April 27, 2021

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Canada NewsWire April 26, 2021

Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants

Canada NewsWire April 26, 2021

Psychedelics Could Play a Crucial Role in Your Mental Health Treatment

Livemoney April 14, 2021

Industry Leaders Look To Artificial Intelligence To Drive Advancements In Mental Healthcare

Livemoney April 14, 2021

The StockTalk Cannabis Report: Apr 2, 2021

Dave Jackson April 2, 2021

As More People Turn to Psychedelics, this Stock Keeps Climbing

Jonathon Brown March 31, 2021

Numinus Announces Closing of $40-Million Bought Deal Financing

Canada NewsWire March 19, 2021

More People Are Turning to Psychedelics to Treat Mental Health Issues

Livemoney March 18, 2021

Health Conscious Consumers are Rapidly Turning to Functional Mushrooms

Livemoney March 16, 2021